418 related articles for article (PubMed ID: 37470668)
41. Long non-coding RNAs in lung cancer: implications for lineage plasticity-mediated TKI resistance.
Liu T; Han C; Fang P; Zhu H; Wang S; Ma Z; Zhang Q; Xia W; Wang J; Xu L; Yin R
Cell Mol Life Sci; 2021 Mar; 78(5):1983-2000. PubMed ID: 33170304
[TBL] [Abstract][Full Text] [Related]
42. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
43. Surmounting cancer drug resistance: New insights from the perspective of N
Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
[TBL] [Abstract][Full Text] [Related]
44. Stem cell plasticity in development and cancer: epigenetic origin of cancer stem cells.
Shah M; Allegrucci C
Subcell Biochem; 2013; 61():545-65. PubMed ID: 23150267
[TBL] [Abstract][Full Text] [Related]
45. Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity.
Skrypek N; Goossens S; De Smedt E; Vandamme N; Berx G
Trends Genet; 2017 Dec; 33(12):943-959. PubMed ID: 28919019
[TBL] [Abstract][Full Text] [Related]
46. PHF6 regulates phenotypic plasticity through chromatin organization within lineage-specific genes.
Soto-Feliciano YM; Bartlebaugh JME; Liu Y; Sánchez-Rivera FJ; Bhutkar A; Weintraub AS; Buenrostro JD; Cheng CS; Regev A; Jacks TE; Young RA; Hemann MT
Genes Dev; 2017 May; 31(10):973-989. PubMed ID: 28607179
[TBL] [Abstract][Full Text] [Related]
47. Epigenetic dynamics of stem cells and cell lineage commitment: digging Waddington's canal.
Hemberger M; Dean W; Reik W
Nat Rev Mol Cell Biol; 2009 Aug; 10(8):526-37. PubMed ID: 19603040
[TBL] [Abstract][Full Text] [Related]
48. Epigenetics and metabolism at the crossroads of stress-induced plasticity, stemness and therapeutic resistance in cancer.
Ravindran Menon D; Hammerlindl H; Torrano J; Schaider H; Fujita M
Theranostics; 2020; 10(14):6261-6277. PubMed ID: 32483452
[TBL] [Abstract][Full Text] [Related]
49. Intra-tumour heterogeneity - going beyond genetics.
Caiado F; Silva-Santos B; Norell H
FEBS J; 2016 Jun; 283(12):2245-58. PubMed ID: 26945550
[TBL] [Abstract][Full Text] [Related]
50. The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance.
Beltran H; Hruszkewycz A; Scher HI; Hildesheim J; Isaacs J; Yu EY; Kelly K; Lin D; Dicker A; Arnold J; Hecht T; Wicha M; Sears R; Rowley D; White R; Gulley JL; Lee J; Diaz Meco M; Small EJ; Shen M; Knudsen K; Goodrich DW; Lotan T; Zoubeidi A; Sawyers CL; Rudin CM; Loda M; Thompson T; Rubin MA; Tawab-Amiri A; Dahut W; Nelson PS
Clin Cancer Res; 2019 Dec; 25(23):6916-6924. PubMed ID: 31363002
[TBL] [Abstract][Full Text] [Related]
51. Glutamine Metabolism Regulators Associated with Cancer Development and the Tumor Microenvironment: A Pan-Cancer Multi-Omics Analysis.
Zou J; Du K; Li S; Lu L; Mei J; Lin W; Deng M; Wei W; Guo R
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573287
[TBL] [Abstract][Full Text] [Related]
52. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity.
Jacoby E; Nguyen SM; Fountaine TJ; Welp K; Gryder B; Qin H; Yang Y; Chien CD; Seif AE; Lei H; Song YK; Khan J; Lee DW; Mackall CL; Gardner RA; Jensen MC; Shern JF; Fry TJ
Nat Commun; 2016 Jul; 7():12320. PubMed ID: 27460500
[TBL] [Abstract][Full Text] [Related]
53. Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity.
Chen NM; Neesse A; Dyck ML; Steuber B; Koenig AO; Lubeseder-Martellato C; Winter T; Forster T; Bohnenberger H; Kitz J; Reuter-Jessen K; Griesmann H; Gaedcke J; Grade M; Zhang JS; Tsai WC; Siveke J; Schildhaus HU; Ströbel P; Johnsen SA; Ellenrieder V; Hessmann E
Gastroenterology; 2017 May; 152(6):1507-1520.e15. PubMed ID: 28188746
[TBL] [Abstract][Full Text] [Related]
54. Mutation-selection balance and compensatory mechanisms in tumour evolution.
Persi E; Wolf YI; Horn D; Ruppin E; Demichelis F; Gatenby RA; Gillies RJ; Koonin EV
Nat Rev Genet; 2021 Apr; 22(4):251-262. PubMed ID: 33257848
[TBL] [Abstract][Full Text] [Related]
55. The epigenetic basis of cellular plasticity.
Paksa A; Rajagopal J
Curr Opin Cell Biol; 2017 Dec; 49():116-122. PubMed ID: 29413970
[TBL] [Abstract][Full Text] [Related]
56. Epigenetic regulation of the lineage specificity of primary human dermal lymphatic and blood vascular endothelial cells.
Tacconi C; He Y; Ducoli L; Detmar M
Angiogenesis; 2021 Feb; 24(1):67-82. PubMed ID: 32918672
[TBL] [Abstract][Full Text] [Related]
57. Impact of hypoxic tumor microenvironment and tumor cell plasticity on the expression of immune checkpoints.
Lequeux A; Noman MZ; Xiao M; Sauvage D; Van Moer K; Viry E; Bocci I; Hasmim M; Bosseler M; Berchem G; Janji B
Cancer Lett; 2019 Aug; 458():13-20. PubMed ID: 31136782
[TBL] [Abstract][Full Text] [Related]
58. Lineage stability and phenotypic plasticity of Foxp3⁺ regulatory T cells.
Hori S
Immunol Rev; 2014 May; 259(1):159-72. PubMed ID: 24712465
[TBL] [Abstract][Full Text] [Related]
59. Addressing intra-tumoral heterogeneity and therapy resistance.
Rybinski B; Yun K
Oncotarget; 2016 Nov; 7(44):72322-72342. PubMed ID: 27608848
[TBL] [Abstract][Full Text] [Related]
60. Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells.
Andriani F; Bertolini G; Facchinetti F; Baldoli E; Moro M; Casalini P; Caserini R; Milione M; Leone G; Pelosi G; Pastorino U; Sozzi G; Roz L
Mol Oncol; 2016 Feb; 10(2):253-71. PubMed ID: 26514616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
